Xin-Yi Loh
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, RNA modifications and cancer, Acute Myeloid Leukemia Research, RNA Research and Splicing, interferon and immune responses
Most-Cited Works
- → Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway(2015)133 cited
- → SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway(2014)78 cited
- → RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling(2019)65 cited
- → LNK suppresses interferon signaling in melanoma(2019)34 cited
- → Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy(2023)21 cited
- → Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia(2016)2 cited
- → Supplementary Tables from Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia(2023)1 cited
- → Supplementary Figure from KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFβ Activity(2023)
- → Data from KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFβ Activity(2023)
- → Supplementary Data from KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFβ Activity(2023)